Trevi Therapeutics
TRVI
#4835
Rank
A$2.79 B
Marketcap
A$19.70
Share price
-0.21%
Change (1 day)
107.91%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2025 (TTM): -A$65.64 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. , an increase over its 2024 earnings that were of -A$66.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -A$59.71 Million-10.67%
2024 -A$66.84 Million67%
2023 -A$40.03 Million2.43%
2022 -A$39.08 Million-14.45%
2021 -A$45.68 Million1.36%
2020 -A$45.07 Million23.64%
2019 -A$36.45 Million27.54%
2018 -A$28.58 Million